Abstract:
Infections caused by extended-spectrum beta-lactamases (ESBL) producing Gram-negative
bacteria has emerge as a global threat in clinical practices. The treat is more serious in
developing countries due to inappropriate use, poor adherence, use of counterfeit, sub-standard
antibiotics and poor infection control practices. Data on ESBL producing Gram-negative
bacteria are limited in developing countries including Ethiopia. The aim of this study was
therefore, to describe the burden of ESBL producing Gram negative pathogens isolated
from patients attending at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar,
Amhara region.
